相关实验视频
Updated: Sep 19, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.7K
第一个选择性IIb类希斯脱乙酶降解剂的开发和表征
Shiyang Zhai1, Irina Honin1, Linda Schäker-Hübner1
1Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.
Journal of medicinal chemistry
|June 18, 2025
概括
研究人员开发了新的蛋白质溶解向嵌合体 (PROTACs) 来选择性地降解基因组脱乙酶 (HDACs) 6和10. 化合物AP1有效地针对这些IIb类HDAC,而不影响其他HDAC类,为癌症研究提供了一个有前途的工具.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白质分解的仿真体 (PROTACs) 是一种针对向蛋白质降解的新型治疗策略.
- 基因组脱乙酶 (HDACs) 与各种疾病有关,这使得它们成为有吸引力的治疗点.
研究的目的:
- 设计,合成和评估第一个选择性降解剂的IIb类基因素脱乙酶 (HDACs) 6和10.
- 开发一种用于向蛋白质敲击的化学工具,在癌症治疗中具有潜在的应用.
主要方法:
- 使用PROTAC技术,将双重HDAC6/10抑制剂 (图巴斯胺A类似物) 与大脑的招募剂 (波马利多米德和基胺胺) 相结合.
- 合成和生物评估的新型PROTAC化合物.
- 对不同HDAC类 (I,IIa,IIb) 的化合物选择性进行评估,并在癌症细胞系中评估细胞毒性.
主要成果:
- 发现了AP1,它是一种强大的HDAC6 (DC50 = 13nM) 和HDAC10 (DC50 = 29nM) 的降解剂.
- 证明了AP1对IIb类HDAC的选择性,没有显示HDAC1/8 (I类) 或HDAC4/7 (IIa类) 的降解.
- 证实了AP1缺乏基因素H3过乙化,这表明特定的目标参与.
- 观察到AP1对血液和固体癌细胞系的低细胞毒性.
结论:
- AP1是第一个被确定为IIb类HDACs (HDAC6和HDAC10) 的选择性降解剂.
- AP1表现出高强度和选择性,使其成为一种有价值的工具化合物.
- AP1的有利细胞毒性概况表明它在涉及IIb类HDACs的疾病的化学淘汰策略中具有潜在的实用性.
相关概念视频
Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K
Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K
Histone Modification
14.1K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
14.1K

